Abbott India Limited (NSE:ABBOTINDIA) — Market Cap & Net Worth

$6.01 Billion USD · Rs555.56 Billion INR · Rank #3223

Market Cap & Net Worth: Abbott India Limited (ABBOTINDIA)

Abbott India Limited (NSE:ABBOTINDIA) has a market capitalization of $6.01 Billion (Rs555.56 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #3223 globally and #142 in its home market, demonstrating a -1.17% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Abbott India Limited's stock price Rs26145.00 by its total outstanding shares 21249302 (21.25 Million). Review ABBOTINDIA total liabilities to assess the company's total debt and financial obligations.

Abbott India Limited Market Cap History: 2015 to 2026

Abbott India Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.29 Billion to $6.01 Billion (16.58% CAGR).

Index Memberships

Abbott India Limited is a constituent of 8 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY PHARMA CNXPHARMA	$92.18 Billion	6.52%	#8 of 20
NIFTY100 EQUAL WEIGHT NIFTY100EW	$1.77 Trillion	0.34%	#64 of 99
NIFTY 500 NIFTY500	$3.15 Trillion	0.19%	#132 of 500
NIFTY HEALTHCARE NIFTYHEALTHCARE	$111.01 Billion	5.41%	#10 of 20
NIFTY MIDCAP 150 NIFTYMIDCAP150	$719.90 Billion	0.83%	#53 of 150
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.15 Trillion	0.52%	#62 of 400
NIFTY MNC NIFTYMNC	$233.56 Billion	2.57%	#12 of 30
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.24 Trillion	0.19%	#130 of 750

Weight: Abbott India Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Abbott India Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Abbott India Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.10x

Abbott India Limited's market cap is 0.10 times its annual revenue

Industry average: 0.53x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.47x

Abbott India Limited's market cap is 0.47 times its annual earnings

Industry average: 0.02x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$1.02 Billion	$26.05 Billion	$2.55 Billion	0.04x	0.40x
2017	$1.20 Billion	$28.93 Billion	$2.77 Billion	0.04x	0.43x
2018	$1.64 Billion	$33.00 Billion	$4.01 Billion	0.05x	0.41x
2019	$2.86 Billion	$36.76 Billion	$4.50 Billion	0.08x	0.64x
2020	$3.48 Billion	$40.91 Billion	$5.93 Billion	0.08x	0.59x
2021	$4.33 Billion	$43.08 Billion	$6.91 Billion	0.10x	0.63x
2022	$4.77 Billion	$49.10 Billion	$7.99 Billion	0.10x	0.60x
2023	$5.18 Billion	$53.47 Billion	$9.49 Billion	0.10x	0.55x
2024	$6.83 Billion	$58.47 Billion	$12.01 Billion	0.12x	0.57x
2025	$6.67 Billion	$64.07 Billion	$14.14 Billion	0.10x	0.47x

Competitor Companies of ABBOTINDIA by Market Capitalization

Companies near Abbott India Limited in the global market cap rankings as of June 19, 2026.

Key companies related to Abbott India Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#515	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#555	GALDERMA GROUP AG	NYSE:GALDY	$48.78 Billion	$42.94
#601	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.20 Billion	CN¥48.42
#627	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€13.30

Abbott India Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Abbott India Limited's market cap moved from $1.29 Billion to $ 6.01 Billion, with a yearly change of 16.58%.

Year	Market Cap	Change (%)
2026	Rs6.01 Billion	-9.92%
2025	Rs6.67 Billion	-2.41%
2024	Rs6.83 Billion	+32.03%
2023	Rs5.18 Billion	+8.44%
2022	Rs4.77 Billion	+10.35%
2021	Rs4.33 Billion	+24.42%
2020	Rs3.48 Billion	+21.36%
2019	Rs2.86 Billion	+75.20%
2018	Rs1.64 Billion	+36.14%
2017	Rs1.20 Billion	+18.10%
2016	Rs1.02 Billion	-20.86%
2015	Rs1.29 Billion	--

End of Day Market Cap According to Different Sources

On Jun 19th, 2026 the market cap of Abbott India Limited was reported to be:

Source	Market Cap
Yahoo Finance	$6.01 Billion USD
MoneyControl	$6.01 Billion USD
MarketWatch	$6.01 Billion USD
marketcap.company	$6.01 Billion USD
Reuters	$6.01 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Abbott India Limited

NSE:ABBOTINDIA India Drug Manufacturers - Specialty & Generic

Market Cap

$6.01 Billion

Rs555.56 Billion INR

Market Cap Rank

#3223 Global

#142 in India

Share Price

Rs26145.00

Change (1 day)

+0.73%

52-Week Range

Rs25180.00 - Rs35670.00

All Time High

Rs35670.00